[e-drug] A National drug policy for Sri Lanka

e-drug
1

Dear E-Druggers,

I am an assistant lecturer working at the Dept. of Pharmacology, Univ. of Ruhuna, Sri Lanka. The Health Ministry in our country is planning to implement a National Drug Policy and I need your assistance in drafting our proposals for it. Please let me know the methods adopted in your countries with respect to the following issues:

1. Limiting the number of products registered under one generic name.

2. Identify and limit me-too drugs.

3. Post Marketing Quality Assurance of Drugs.

Thank you!

Dr.Ruwan Chandana
Department of Pharmacology
University of Ruhuna,Sri Lanka.
T.P. +94 912234801 Ext.345
Mobile +94 777257803
Fax. +94 912222314
ruwanprsd@yahoo.com

[The WHO webpage for NDP implementation is at: http://www.who.int/medicines/strategy/policy/stpolndp.shtml

The WHO Guidelines can be ordered at: http://www.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=2287

A useful (free!) 6-pager is also at:
http://www.who.int/medicines/library/edm_general/6pagers/No6-6pg-en.pdf

WB]

2

E-DRUG: A National drug policy for Sri Lanka (2)
------------------------------------------------

Dear Dr. Ruwan Chandana

Please visit the http://www.pakistan.gov.pk/health-ministry/ or
www.dcomoh.gov.pk you will find the text of national drug policy of
Pakistan and while going through you will be able to find the answers. If
any further query please do contact me.

Best Regards,

Azhar Hussian
Acting Director (Assistant Professor)
Hamdard Institute of Pharmaceutical Sciences
Hamdard University, F-8 Markaz
Islamabad, Pakistan.
Tel:00-92-51-2856901EXt-217
Fax:00-92-51-2856403